Laguna-dana Urgent Care Inc | |
24060 Camino Del Avion Suite A Monarch Beach CA 92629-4006 | |
(949) 248-8900 | |
(949) 248-8901 |
Full Name | Laguna-dana Urgent Care Inc |
---|---|
Speciality | Clinic/Center |
Location | 24060 Camino Del Avion, Monarch Beach, California |
Authorized Official Name and Position | Robert Craig Amster (CEO) |
Authorized Official Contact | 7143895700 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Laguna-dana Urgent Care Inc 18231 Irvine Blvd Ste 204 Tustin CA 92780-3432 Ph: (714) 389-5700 | Laguna-dana Urgent Care Inc 24060 Camino Del Avion Suite A Monarch Beach CA 92629-4006 Ph: (949) 248-8900 |
NPI Number | 1063693653 |
---|---|
Provider Enumeration Date | 11/24/2007 |
Last Update Date | 05/16/2011 |
Medicare PECOS PAC ID | 4789760307 |
---|---|
Medicare Enrollment ID | O20080324000592 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
Patients with a rare form of cancer called advanced soft tissue sarcoma could now benefit from a new drug called trabectedin, after the National Institute for Health and Clinical Excellence (NICE) approved the drug for NHS use.
Twenty-eight Republican senators said Thursday that the Obama administration should not stop the state of Indiana from implementing a new law designed to cut off federal funding for Planned Parenthood. Earlier this month, the federal Medicaid agency denied Indiana's proposal to prevent state residents from using Medicaid at any entity that provides abortions.
Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades.
AvidBiologics Inc., a life sciences company developing antibody-drug conjugates (ADCs), announces the conclusion of an agreement with the National Research Council Canada (NRC) to develop three novel ADCs for the treatment of cancer.
› Verified 9 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1063693653 | NPI | - | NPPES |
Provider Name | Robert C Amster |
---|---|
Provider Type | Practitioner - Emergency Medicine |
Provider Identifiers | NPI Number: 1972706083 PECOS PAC ID: 9032007943 Enrollment ID: I20040310000747 |
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
Patients with a rare form of cancer called advanced soft tissue sarcoma could now benefit from a new drug called trabectedin, after the National Institute for Health and Clinical Excellence (NICE) approved the drug for NHS use.
Twenty-eight Republican senators said Thursday that the Obama administration should not stop the state of Indiana from implementing a new law designed to cut off federal funding for Planned Parenthood. Earlier this month, the federal Medicaid agency denied Indiana's proposal to prevent state residents from using Medicaid at any entity that provides abortions.
Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades.
AvidBiologics Inc., a life sciences company developing antibody-drug conjugates (ADCs), announces the conclusion of an agreement with the National Research Council Canada (NRC) to develop three novel ADCs for the treatment of cancer.
› Verified 9 days ago
News Archive
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.
Patients with a rare form of cancer called advanced soft tissue sarcoma could now benefit from a new drug called trabectedin, after the National Institute for Health and Clinical Excellence (NICE) approved the drug for NHS use.
Twenty-eight Republican senators said Thursday that the Obama administration should not stop the state of Indiana from implementing a new law designed to cut off federal funding for Planned Parenthood. Earlier this month, the federal Medicaid agency denied Indiana's proposal to prevent state residents from using Medicaid at any entity that provides abortions.
Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate, and 39 percent over age 65 take five or more, a number that's increased three-fold in the last several decades.
AvidBiologics Inc., a life sciences company developing antibody-drug conjugates (ADCs), announces the conclusion of an agreement with the National Research Council Canada (NRC) to develop three novel ADCs for the treatment of cancer.
› Verified 9 days ago